[1]
“Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study”, AJBR, c. 22, sy 3, ss. 347–352, Ara. 2019, Erişim: 26 Haziran 2026. [çevrimiçi]. Erişim adresi: https://ojshostng.com/index.php/ajbr/article/view/1335